Adimmune Corp. | Cash Flow
Fiscal year is January-December. All values TWD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
664,799.00
659,054.00
731,070.00
627,563.00
776,971.00
665,914
Depreciation, Depletion & Amortization
295,089.00
299,432.00
305,204.00
291,747.00
291,850.00
258,131
Other Funds
3,562.00
294,000.00
13,533.00
41,444.00
1,029.00
13,498
Funds from Operations
329,211.00
293,674.00
422,269.00
328,979.00
338,277.00
394,285
Changes in Working Capital
236,191.00
123,680.00
48,452.00
444,551.00
345,151.00
207,455
Net Operating Cash Flow
565,402.00
417,354.00
373,817.00
773,530.00
6,874.00
601,740
Capital Expenditures
63,464.00
20,398.00
8,713.00
88,461.00
26,320.00
Sale of Fixed Assets & Businesses
2.00
333.00
-
-
40,334.00
Purchase/Sale of Investments
5,000.00
5,000.00
1,686.00
381,358.00
72,561.00
Net Investing Cash Flow
49,501.00
21,637.00
11,924.00
443,334.00
58,481.00
Issuance/Reduction of Debt, Net
22,532.00
862,829.00
341,910.00
1,898,010.00
398,010.00
Net Financing Cash Flow
25,670.00
941,122.00
319,087.00
1,944,730.00
383,799.00
Net Change in Cash
589,233.00
502,131.00
66,654.00
727,866.00
435,406.00
Free Cash Flow
628,866.00
437,752.00
382,530.00
861,807.00
18,998.00
Other Sources
18,961.00
3,428.00
-
26,485.00
66.00
Change in Capital Stock
51,764.00
1,509,951.00
36,356.00
5,276.00
15,240.00
Other Uses
-
-
1,525.00
-
-
About Adimmune
View Profile
